USPTO serial 79384162
IMMUNOPLUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 11, 2024
- Examiner
- BARRETT, LEAH N
- Law office
- TMEG LAW OFFICE 106
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMMUNOPLUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nanjing GenScript Biotech Co., Ltd.
- Other trademarks owned by Nanjing GenScript Biotech Co., Ltd.
- Other trademarks owned by Nanjing GenScript Biotech Co., Ltd.
- Other trademarks in Class 042
- Similar marks named IMMUNOPLUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 29, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 29, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 11, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2024 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 30, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |